Kepos Capital LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 231 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$815,000
-87.2%
6,007
-74.1%
0.06%
-80.7%
Q3 2018$6,361,000
+2.0%
23,173
-23.0%
0.33%
+2.5%
Q2 2018$6,235,000
+79.1%
30,096
+42.8%
0.32%
+55.9%
Q1 2018$3,482,00021,0800.20%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders